Arthritis · Irving, TX
Arthritis studies in Irving, TX
4 recruiting studies have a site in Irving.
4 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Irving, TX + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Janssen Research & Development, LLC
- Location
- Irving, TX + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Artiva Biotherapeutics, Inc.
- Location
- Irving, TX + 29 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
Surf Therapeutics
- Location
- Irving, TX + 2 other US sites
- Eligibility basics
- Ages 18+
Who these studies look for
Most require a confirmed diagnosis, often with X-rays or blood tests, and set rules for pain medicines during the study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.